CVE:ICO iCo Therapeutics (ICO) Stock Price, News & Analysis → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free ICO Stock Alerts C$0.10 0.00 (0.00%) (As of 03/19/2021) Add Compare Share Share Today's RangeC$0.10▼C$0.1150-Day RangeC$0.11▼C$0.1152-Week RangeC$0.02▼C$0.16Volume1.31 million shsAverage Volume3.16 million shsMarket CapitalizationC$951,825.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get iCo Therapeutics alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About iCo Therapeutics Stock (CVE:ICO)iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed drug candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.Read More ICO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICO Stock News HeadlinesApril 24, 2024 | msn.com‘The moment I knew I would never speak to Sharon Osbourne again after X Factor’April 19, 2024 | msn.comX Factor winner releases surprise new single with global superstar singerApril 25, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? April 17, 2024 | investing.comEnlivex Therapeutics Ltd (ENLV)April 14, 2024 | msn.comIs Covid still a threat four years on from the first wave?April 13, 2024 | msn.comThe next Zelda game should be spin-off without Link – Reader’s FeatureApril 12, 2024 | msn.comMinishoot’ Adventures review – Zelda in a spaceshipApril 9, 2024 | msn.comX Factor legends Jedward say Louis Walsh ‘took advantage’ of themApril 25, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? March 31, 2024 | msn.comX Factor star announces engagement and reveals Simon Cowell’s huge role at weddingMarch 31, 2024 | msn.comX Factor star reveals huge role Simon Cowell is going to play at her weddingMarch 29, 2024 | msn.comX Factor icon announces engagement to boyfriendMarch 27, 2024 | msn.comNew pictures show Cara Delevingne’s fire-ravaged $7,000,000 home in ruinsMarch 26, 2024 | msn.comZelda movie director wants to make a ‘serious’ but ‘whimsical’ filmMarch 22, 2024 | msn.comX Factor winner Matt Terry comes out 7 years after rising to fame on showMarch 17, 2024 | msn.comGrammy-nominated X Factor star finally releasing debut album 16 years onMarch 16, 2024 | msn.comX Factor reject overjoyed as she marries partner – but famous sister is absent amid family feudMarch 15, 2024 | msn.comWhat you could be buying at Meghan Markle’s American Riviera OrchardMarch 14, 2024 | msn.comSinger says Louis Walsh’s Jedward comments are ‘tip of iceberg of abuse’ on X FactorMarch 4, 2024 | msn.comX Factor runner-up is unrecognisable in jaw-dropping American Idol auditionFebruary 28, 2024 | msn.comLeap Year brings unexpected proposals – ready to find out your star sign’s Leap Day forecast?February 27, 2024 | msn.comX Factor winner unrecognisable after suffering career heartbreakFebruary 27, 2024 | msn.comThis X Factor winner is unrecognisable 8 years after victoryFebruary 26, 2024 | msn.comX Factor winner’s unexpected response after selling just 27 tickets for cancelled gigFebruary 25, 2024 | msn.comCelebrity Big Brother tipped for utter chaos with Sharon Osbourne and Louis Walsh reunionFebruary 25, 2024 | msn.comX Factor winner forced to cancel show after selling just 27 ticketsFebruary 6, 2024 | msn.comRylan Clark shocked himself by how he dealt with X Factor star Lucy Spraggan’s rapeSee More Headlines Receive ICO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:ICO CUSIPN/A CIKN/A Webwww.icotherapeutics.com Phone+1-604-6029414FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.14 Quick Ratio1.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.01 per share Price / Cash Flow8.75 Book ValueC$0.00 per share Price / Book105.00Miscellaneous Outstanding Shares9,065,000Free FloatN/AMarket CapC$951,825.00 OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. William Wasyl Jarosz (Age 65)Chairman & CEO Mr. Michael Liggett B.Sc. (Age 61)C.A., C.P.A., CPA, CA, Bsc. Pharm., CFO, Corp. Sec. & Director Comp: $42.45kDr. Peter Hnik (Age 65)Chief Medical Officer & Director Key CompetitorsPascal BiosciencesCVE:PASCotinga Pharmaceuticals Inc. (COT.V)CVE:COTBioasis TechnologiesCVE:BTISolarvest BioEnergyCVE:SVSMedifocus Inc. (MFS.V)CVE:MFSView All Competitors ICO Stock Analysis - Frequently Asked Questions How have ICO shares performed in 2024? iCo Therapeutics' stock was trading at C$0.11 at the beginning of the year. Since then, ICO stock has increased by 0.0% and is now trading at C$0.11. View the best growth stocks for 2024 here. What other stocks do shareholders of iCo Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other iCo Therapeutics investors own include iCo Therapeutics (ICOTF), Theratechnologies (TH), Regulus Therapeutics (RGLS), Nemaska Lithium (NMX), Freeport-McMoRan (FCX), Eldorado Gold (EGO), Dextera Surgical (DXTR), Ag Growth International (AFN), Aurora Cannabis (ACBFF) and How do I buy shares of iCo Therapeutics? Shares of ICO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ICO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
